Validating the hen as a bioreactor for the production of exogenous proteins in egg white.
Increased demand for the production of human biopharmaceuticals in transgenic organisms has led to an intensive effort to develop the hen as a bioreactor producing exogenous proteins in egg white via transgenesis. To date, however, robust methods for transgenic modification of the avian genome have been lacking. We have used a replication-defective retroviral vector derived from avian leukosis virus (ALV) to generate transgenic chickens expressing bacterial beta-lactamase secreted into serum and egg whites through several generations. Expression was driven by the ubiquitous cytomegalovirus (CMV) promoter. Here we describe results from a transgenic lineage (Harvey et al., 2002a,b) in which (1) the transgene was stably transmitted from a G1 founder male (5657) through several generations without silencing, (2) the protein was biologically active, and (3) the level of expression in egg whites was doubled in a G3 homozygote.
Harvey
A J
AJ
AviGenics, Inc., Georgia BioBusiness Center, 111 Riverbend Road, Athens, Georgia 30605, USA.
Ivarie
R
R
D000818:Animals; D030801:Animals, Genetically Modified; D019149:Bioreactors; D002645:Chickens; D004529:Egg White; D005786:Gene Expression Regulation; D005818:Genetic Engineering; D005822:Genetic Vectors; D010063:Ovum; D014176:Protein Biosynthesis; D012190:Retroviridae